Glutathione S-transferase T1-and M1-null genotypes and coronary artery disease risk in patients with type 2 diabetes mellitus

Pharmacogenomics

Volumn 10, Issue 1, 2009, Pages 29-34

  Manfredi, Samantha ^a   Calvi, Debora ^a   del Flandra, Martina ^a   Botto, Nicoletta ^a   Biagini, Andrea ^a   Andreassi, Maria Grazia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Cardiovascular risk; Coronary artery disease; Glutathione S transferase; Oxidative stress; Smoking; Type 2 diabetes

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DYSLIPIDEMIA; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SMOKING HABIT; ENZYMOLOGY; GENETICS; RISK; SMOKING;

AGED; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK; SEX FACTORS; SMOKING;

EID: 62649155340     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.10.1.29     Document Type: Article

References (29)

1. Laakso M, Lehto S: Epidemiology of macrovascular disease in diabetes. Diabetes Rev. 5(2), 294-315 (1997).
2. Haffner SM, Lehto S, Rönnemaa T, Pyorala K, Laasko M: Mortality from coronary heart disease in subjects with Type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339(4), 229-234 (1998).
3. Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. J. Am. Med. Assoc. 281(14), 1291-1297 (1999).
4. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16(2), 434-444 (1993).
5. Laakso M, Lehto S: Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 137(Suppl.), S65-S73 (1998).
6. Eliasson B: Cigarette smoking and diabetes. Prog. Cardiovasc. Dis. 45 (5), 405-413 (2003).
7. Levy AP: Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene. Acta Diabetol. 40 (Suppl. 2), S330-S333 (2003).
8. Ruiz J: Diabetes mellitus and late complications: influence of genetic factors. Diabet. Med. 23(Suppl. 2), 57-63 (1997).
9. Giugliano D, Paolisso G, Ceriello A: Oxidative stress and diabetic vascular complications. Diabetes Care 19(3), 257-267 (1996).
10. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865), 813-820 (2001).
11. Ketterer B: Glutathione S-transferases and prevention of cellular free radical damage. Free Radic. Res. 28(6), 647-658 (1998).
12. Hayes JD, Flanagan JU, Jowsey IR: Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51-88 (2005).
13. Masetti S, Botto N, Manfredi S et al.: Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J. Mol. Med. 81(8), 488-494 (2003).
14. Tamer L, Ercan B, Camsari A et al.: Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Res. Cardiol. 99(3), 223-229 (2004).
15. Abu-Amero KK, Al-Boudari OM, Mohamed GH, Dzimiri N: T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking. BMC Med. Genet. 7, 38 (2006).
16. Gauderman WJ: Sample size requirements for association studies of gene-gene interaction. Am. J. Epidemiol. 155(5), 478-484 (2002).
17. Hayek T, Stephens JW, Hubbart CS et al.: A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus. Atherosclerosis 184(2), 404-412 (2006).
18. Wang G, Zhang L, Li Q: Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population. Biochem. Biophys. Res. Commun. 341(2), 310-313 (2006).
19. Doney AS, Lee S, Leese GP, Morris AD, Palmer CN: Increased cardiovascular morbidity and mortality in Type 2 diabetes is associated with the glutathione S transferase τ-null genotype: a Go-DARTS study. Circulation 111(22), 2927-2934 (2005).
20. Hori M, Oniki K, Ueda K et al.: Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against Type 2 diabetes in Japanese. Pharmacogenomics 8(10), 1307-1314 (2007).
21. Fujita H, Narita T, Meguro H et al.: No association of glutathione S-transferase M1 gene polymorphism with diabetic nephropathy in Japanese Type 2 diabetic patients. Ren. Fail. 22(4), 479-486 (2000).
22. Yang Y, Kao MT, Chang CC et al.: Glutathione S-transferase T1 deletion is a risk factor for developing end-stage renal disease in diabetic patients. Int. J. Mol. Med. 14(5), 855-859 (2004).
23. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE: Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int. J. Epidemiol. 30(3), 540-546 (2001).
24. Andreassi MG: Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat. Res. 543(1), 67-86 (2003).
25. Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T: Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 42(8), 995-998 (1999).
26. Dandona P, Thusu K, Cook S et al.: Oxidative damage to DNA in diabetes mellitus. Lancet 347(8999), 444-445 (1996).
27. Andreassi MG, Botto N, Simi S et al.: Diabetes and chronic nitrate therapy as codeterminants of somatic DNA damage in patients with coronary artery disease. J. Mol. Med. 83(4), 279-286 (2005).
28. Szabo C: PARP as a drug target for the therapy of diabetic cardiovascular dysfunction. Drug News Perspect. 15(4), 197-205 (2002).
29. Dusinska M, Ficek A, Horska A et al.: Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat. Res. 482(1-2), 47-55 (2001).